Common use of SEC Filings; Disclosure Clause in Contracts

SEC Filings; Disclosure. The Company has filed with the SEC all reports, schedules and statements required to be filed by it under the Exchange Act on a timely basis for the most recent twelve-month period. As of their respective filing dates, the Public Filings filed since January 1, 2023 complied in all material respects with applicable accounting requirements and the requirements of the Exchange Act, and the rules and regulations of the SEC promulgated thereunder applicable to such Public Filings, were prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto or, in the case of unaudited statements, as permitted by Form 10-Q of the SEC), fairly present (subject in the case of unaudited statements to normal, recurring and year end audit adjustments) in all material respects the consolidated financial position of the Company as of the dates thereof and the consolidated results of its operations and cash flows for the periods then ended, and none of such Public Filings, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Other than the Transactions and the Other Transactions, as of the date hereof, no material event or circumstance has occurred which would be required to be publicly disclosed or announced pursuant to the provisions of the SEC’s Form 8-K which has not been so publicly announced or disclosed on Form 8-K.

Appears in 2 contracts

Samples: Convertible Notes Exchange Agreement (Biora Therapeutics, Inc.), Convertible Notes Exchange Agreement (Biora Therapeutics, Inc.)

AutoNDA by SimpleDocs

SEC Filings; Disclosure. The Company has filed with the SEC all reports, schedules and statements required to be filed by it under the Exchange Act on a timely basis for the most recent twelve-month period. As of their respective filing dates, the Public Filings filed since January 1, 2023 complied in all material respects with applicable accounting requirements and the requirements of the Exchange Act, and the rules and regulations of the SEC promulgated thereunder applicable to such Public Filings, were prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto or, in the case of unaudited statements, as permitted by Form 10-Q of the SEC), fairly present (subject in the case of unaudited statements to normal, recurring and year year-end audit adjustments) in all material respects the consolidated financial position of the Company as of the dates thereof and the consolidated results of its operations and cash flows for the periods then ended, and none of such Public Filings, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Other than the Transactions and the Other Transactions, as of the date hereof, no material event or circumstance has occurred which would be required to be publicly disclosed or announced pursuant to the provisions of the SEC’s Form 8-K which has not been so publicly announced or disclosed on Form 8-K.

Appears in 2 contracts

Samples: Convertible Notes Purchase Agreement (Biora Therapeutics, Inc.), Convertible Notes Purchase Agreement (Biora Therapeutics, Inc.)

SEC Filings; Disclosure. The Company has filed with the SEC all reports, schedules and statements required to be filed by it under the Exchange Act on a timely basis for the most recent twelve-month period. As of their respective filing dates, the Public Filings filed since January 1, 2023 complied in all material respects with applicable accounting requirements and the requirements of the Exchange Act, and the rules and regulations of the SEC promulgated thereunder applicable to such Public Filings, were prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto or, in the case of unaudited statements, as permitted by Form 10-Q of the SEC), fairly present (subject in the case of unaudited statements to normal, recurring and year year-end audit adjustments) in all material respects the consolidated financial position of the Company as of the dates thereof and the consolidated results of its operations and cash flows for the periods then ended, and none of such Public Filings, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Other than the Transactions and the Other Exchange Transactions, as of the date hereof, no material event or circumstance has occurred which would be required to be publicly disclosed or announced pursuant to the provisions of the SEC’s Form 8-K which has not been so publicly announced or disclosed on Form 8-K.

Appears in 1 contract

Samples: Convertible Notes Purchase Agreement (Biora Therapeutics, Inc.)

SEC Filings; Disclosure. (a) The Company has furnished or there is available to the Purchasers, via its XXXXX filings with the SEC, true and complete copies of the Company’s Annual Report on Form 20-F for the fiscal year ended April 30, 2004 and all other reports filed with or registration statements declared effective by the SEC since April 30, 2004, which are all the documents that the Company was required to file with the SEC since that date, other than with respect to the Company’s Annual Report on Form 20-F for the fiscal year ended April 30, 2005, a Board-approved draft of which has been made available to the Purchasers (the “2005 20-F”) (the documents referred to above, together with all reportsaccompanying exhibits and all information incorporated therein by reference, schedules being referred to herein collectively as the “Company SEC Reports” and statements required the Company SEC Reports filed with or declared effective by the SEC prior to be filed by it under the date of this Agreement, the “Filed SEC Reports”). The Company has timely made all filings and furnishings with the SEC pursuant to the Exchange Act on a timely basis for during the most recent twelve12 months preceding the date of this Agreement (other than with respect to the 2005 20-month periodF). As of their respective filing dates, the Public Filings Company SEC Reports were duly filed since January 1, 2023 or furnished (other than with respect to the 2005 20-F regarding requirements of time of filing) with the SEC and complied in all material respects with applicable accounting requirements and the requirements of the Xxxxxxxx-Xxxxx Act of 2002, the Securities Act or the Exchange Act, as the case may be, and the rules and regulations of promulgated by the SEC promulgated and NASDAQ Stock Market thereunder applicable to such Public FilingsCompany SEC Reports (other than with respect to the 2005 20-F regarding requirements of time of filing). As of their respective dates, were prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto or, in the case of unaudited statements, as permitted by Form 10-Q of the SEC), fairly present (subject in the case of unaudited statements to normal, recurring and year end audit adjustments) in all material respects the consolidated financial position none of the Company as of the dates thereof and the consolidated results of its operations and cash flows for the periods then endedSEC Reports contained, and none of such Public Filingswhen filed, at the time they were filed with the SEC2005 20-F shall not contain, contained any untrue statement of a material fact or omitted (or omit, in the case of the 2005 20-F) to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Other than The audited consolidated financial statements included in the Transactions Company SEC Reports comply, and the Other Transactionsaudited consolidated financial statements that will be included in the 2005 20-F shall comply, as in all material respects with applicable accounting requirements of the date hereof, no material event Securities Act or circumstance the Exchange Act and with the published rules and regulations of the SEC with respect thereto. (b) The Company has occurred which would be required to be publicly disclosed or announced pursuant to the provisions Purchasers all agreements, instruments and corporate or other restrictions to which it or any of its Subsidiaries is subject, and all other matters known to it, that, individually or in the SEC’s Form 8-K which has not been so publicly announced or disclosed on Form 8-K.aggregate, would reasonably be expected to result in a Material Adverse Effect.

Appears in 1 contract

Samples: Securities Purchase Agreement (Asat Holdings LTD)

SEC Filings; Disclosure. The Company has filed with the SEC all reports, schedules and statements required to be filed by it under the Exchange Act on a timely basis for the most recent twelve-month period. As of their respective filing dates, the Public Filings filed since January 1, 2023 2024, complied in all material respects with applicable accounting requirements and the requirements of the Exchange Act, Act and the rules and regulations of the SEC promulgated thereunder applicable to such Public Filings; and there are no contracts or other documents that are required to be described in the Public Filings that are not described or filed as required. The consolidated financial statements of the Company included or incorporated by reference in the Public Filings, were prepared together with the 8 related notes and schedules, present fairly, in accordance with GAAP applied on a consistent basis during all material respects, the financial position of the Company and its consolidated subsidiaries as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders’ equity of the Company and its consolidated subsidiaries for the periods involved specified (except as may be indicated in the notes thereto orsubject, in the case of unaudited statements, as permitted by Form 10-Q to normal year- end audit adjustments which will not be material, either individually or in the aggregate) and have been prepared in compliance with the published requirements of the SEC)Securities Act and Exchange Act, fairly present as applicable, and in conformity with generally accepted accounting principles in the United States (subject “GAAP”) applied on a consistent basis (except (i) for such adjustments to accounting standards and practices as are noted therein and (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) during the periods involved; the other financial and statistical data with respect to the Company and its consolidated subsidiaries contained or incorporated by reference in the Public Filings are accurately and fairly presented and prepared on a basis consistent with the financial statements to normal, recurring and year end audit adjustments) in all material respects the consolidated financial position books and records of the Company; there are no financial statements (historical or pro forma) that are required to be included or incorporated by reference in the Public Filings that are not included or incorporated by reference as required; the Company as of and its consolidated subsidiaries do not have any material liabilities or obligations, direct or contingent (including any off balance sheet obligations), not described in the dates thereof and the consolidated results of its operations and cash flows for the periods then ended, and none Public Filings which are required to be described therein. None of such Public Filings, at the time they were filed with the SECSEC or, if amended or restated, as of the date of such amendment or restatement, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Other than the Transactions and the Other Transactions, as of the date hereof, no material event or circumstance has occurred which would be required to be publicly disclosed or announced by the Company pursuant to the provisions of the SEC’s Form 8-K which has not been so publicly disclosed or announced or disclosed on Form 8-K.

Appears in 1 contract

Samples: Purchase Agreement (Luminar Technologies, Inc./De)

AutoNDA by SimpleDocs

SEC Filings; Disclosure. The Company has filed with the SEC all reports, schedules and statements required to be filed by it under the Exchange Act on a timely basis for the most recent twelve-month period. As of their respective filing dates, the Public Filings filed since January 1, 2023 2024, complied in all material respects with applicable accounting requirements and the requirements of the Exchange Act, Act and the rules and regulations of the SEC promulgated thereunder applicable to such Public Filings; and there are no contracts or other documents that are required to be described in the Public Filings that are not described or filed as required. The consolidated financial statements of the Company included or incorporated by reference in the Public Filings, were prepared together with the related notes and schedules, present fairly, in accordance with GAAP applied on a consistent basis during all material respects, the financial position of the Company and its consolidated subsidiaries as of the dates indicated and the consolidated results of operations, cash flows and changes in stockholders’ equity of the Company and its consolidated subsidiaries for the periods involved specified (except as may be indicated in the notes thereto orsubject, in the case of unaudited statements, as permitted by Form 10-Q to normal year- end audit adjustments which will not be material, either individually or in the aggregate) and have been prepared in compliance with the published requirements of the SEC)Securities Act and Exchange Act, fairly present as applicable, and in conformity with generally accepted accounting principles in the United States (subject “GAAP”) applied on a consistent basis (except (i) for such adjustments to accounting standards and practices as are noted therein and (ii) in the case of unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) during the periods involved; the other financial and statistical data with respect to the Company and its consolidated subsidiaries contained or incorporated by reference in the Public Filings are accurately and fairly presented and prepared on a basis consistent with the financial statements to normal, recurring and year end audit adjustments) in all material respects the consolidated financial position books and records of the Company; there are no financial statements (historical or pro forma) that are required to be included or incorporated by reference in the Public Filings that are not included or incorporated by reference as required; the Company as of and its consolidated subsidiaries do not have any material liabilities or obligations, direct or contingent (including any off balance sheet obligations), not described in the dates thereof and the consolidated results of its operations and cash flows for the periods then ended, and none Public Filings which are required to be described therein. None of such Public Filings, at the time they were filed with the SECSEC or, if amended or restated, as of the date of such amendment or restatement, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Other than the Transactions and the Other Transactions, as of the date hereof, no material event or circumstance has occurred which would be required to be publicly disclosed or announced by the Company pursuant to the provisions of the SEC’s Form 8-K which has not been so publicly disclosed or announced or disclosed on Form 8-K.

Appears in 1 contract

Samples: Exchange Agreement (Luminar Technologies, Inc./De)

SEC Filings; Disclosure. The Company has filed with the SEC all reports, schedules and statements required to be filed by it under the Exchange Act on a timely basis for the most recent twelve-month period. As of their respective filing dates, the Public Filings filed since January 1, 2023 complied in all material respects with applicable accounting requirements and the requirements of the Exchange Act, and the rules and regulations of the SEC promulgated thereunder applicable to such Public Filings, were prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto or, in the case of unaudited statements, as permitted by Form 10-Q of the SEC), fairly present (subject in the case of unaudited statements to normal, recurring and year year-end audit adjustments) in all material respects the consolidated financial position of the Company as of the dates thereof and the consolidated results of its operations and cash flows for the periods then ended, and none of such Public Filings, at the time they were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Other than the Transactions and the Other Purchase Transactions, as of the date hereof, no material event or circumstance has occurred which would be required to be publicly disclosed or announced pursuant to the provisions of the SEC’s Form 8-K which has not been so publicly announced or disclosed on Form 8-K.

Appears in 1 contract

Samples: Convertible Notes Exchange Agreement (Biora Therapeutics, Inc.)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!